Literature DB >> 14619958

Eyeing endothelins: a cellular perspective.

Ganesh Prasanna1, Santosh Narayan, Raghu R Krishnamoorthy, Thomas Yorio.   

Abstract

Endothelin is an endogenous vasoactive peptide that is considered among the most potent vasoconstrictor substances known. In addition to its vascular effects, endothelins and their receptors have been shown to be present in the eye and to have a number of ocular actions that may be important for ocular homeostasis, but, in excess can be a potential contributor to ocular neuropathy in glaucoma. The current review focuses on the cellular and molecular aspects of endothelins and its receptors in the eye with an emphasis on its relationship to ocular function and its potential role in the etiology of glaucoma pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619958     DOI: 10.1023/a:1026005418874

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  228 in total

1.  Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling.

Authors:  H J Lee; M Chun; K V Kandror
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

2.  Decoy oligodeoxynucleotide characterization of transcription factors controlling endothelin-B receptor expression in vascular smooth muscle cells.

Authors:  A H Wagner; R Krzesz; D Gao; C Schroeder; M Cattaruzza; M Hecker
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Effects of nitric oxide donors and nitric oxide synthase substrates on ciliary muscle contracted by carbachol and endothelin for possible use in myopia prevention.

Authors:  C Beauregard; Q Liu; G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  2001-02       Impact factor: 2.671

Review 4.  The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology?

Authors:  I O Haefliger; P Meyer; J Flammer; T F Lüscher
Journal:  Surv Ophthalmol       Date:  1994 Sep-Oct       Impact factor: 6.048

5.  Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in cultured human ciliary muscle cells: activation of phospholipase A2.

Authors:  S Y Yousufzai; A A Abdel-latif
Journal:  Exp Eye Res       Date:  1997-07       Impact factor: 3.467

6.  Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-alpha.

Authors:  G Prasanna; A Dibas; W Tao; K White; T Yorio
Journal:  Exp Eye Res       Date:  1998-01       Impact factor: 3.467

Review 7.  Endothelin and neural crest development.

Authors:  H Kurihara; Y Kurihara; R Nagai; Y Yazaki
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1999-07       Impact factor: 1.770

8.  CD63 is a component of Weibel-Palade bodies of human endothelial cells.

Authors:  U M Vischer; D D Wagner
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

9.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J Javitt; K Singh
Journal:  Arch Ophthalmol       Date:  1991-08

10.  Effects of BQ-123, an ETA recepter-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit.

Authors:  M S Haque; K Sugiyama; T Taniguchi; Y Kitazawa
Journal:  Jpn J Ophthalmol       Date:  1996       Impact factor: 2.447

View more
  16 in total

1.  Thrombin-induced endothelin-1 synthesis and secretion in retinal pigment epithelial cells is rho kinase dependent.

Authors:  Santosh Narayan; Ganesh Prasanna; Kissaou Tchedre; Raghu Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

Review 2.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells.

Authors:  Shaoqing He; Yong H Park; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09-01       Impact factor: 4.799

4.  [German Ophthalmology Internationally].

Authors:  T Kohnen
Journal:  Ophthalmologe       Date:  2017-09       Impact factor: 1.059

5.  Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery.

Authors:  Zuhair K Al-Hussaini; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

6.  Neuropathy optic glaucomatosa induced by systemic hypertension through activation endothelin-1 signaling pathway in central retinal artery in rats.

Authors:  Seskoati Prayitnaningsih; Hidayat Sujuti; Maksum Effendi; Aulia Abdullah; Nanda Wahyu Anandita; Febriani Yohana; Nur Permatasari; Mohamad Aris Widodo
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 7.  TNF-alpha signaling in glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

8.  Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors.

Authors:  Wei Xue; Núria Comes; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

9.  Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork.

Authors:  Giulia Renieri; Lars Choritz; Rita Rosenthal; Susann Meissner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-10       Impact factor: 3.117

10.  Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.

Authors:  Alena Z Minton; Nitasha R Phatak; Dorota L Stankowska; Shaoqing He; Hai-Ying Ma; Brett H Mueller; Ming Jiang; Robert Luedtke; Shaohua Yang; Colby Brownlee; Raghu R Krishnamoorthy
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.